ACSF2
Gene Information
- Official Symbol: ACSF2
- Official Name: acyl-CoA synthetase family member 2
- Aliases and Previous Symbols: N/A
- Entrez ID: 80221
- UniProt: Q96CM8
- Interactions: BioGRID
- PubMed articles: Open PubMed
- OMIM: Open OMIM
Function Summary
- Entrez Summary: N/A
- UniProt Summary: Acyl-CoA synthases catalyze the initial reaction in fatty acid metabolism, by forming a thioester with CoA. Has some preference toward medium-chain substrates. Plays a role in adipocyte differentiation. {ECO:0000269|PubMed:16380219, ECO:0000269|PubMed:17762044}.
Pfam Domains GO Terms
Pfam Domains
| AMP-binding |
GO Terms
| acyl-CoA ligase activity |
| acyl-CoA metabolic process |
| thioester metabolic process |
| nucleoside bisphosphate metabolic process |
| ribonucleoside bisphosphate metabolic process |
| purine nucleoside bisphosphate metabolic process |
| coenzyme metabolic process |
| purine ribonucleotide metabolic process |
| fatty acid metabolic process |
| ribonucleotide metabolic process |
| purine nucleotide metabolic process |
| ribose phosphate metabolic process |
| sulfur compound metabolic process |
| purine-containing compound metabolic process |
| mitochondrial matrix |
| cofactor metabolic process |
| nucleotide metabolic process |
| nucleoside phosphate metabolic process |
| monocarboxylic acid metabolic process |
| nucleobase-containing small molecule metabolic process |
| cellular amide metabolic process |
| organophosphate metabolic process |
| carboxylic acid metabolic process |
| cellular lipid metabolic process |
| oxoacid metabolic process |
| organic acid metabolic process |
| carbohydrate derivative metabolic process |
| lipid metabolic process |
| ATP binding |
| small molecule metabolic process |
CRISPR Data
Compound Hit Most Correlated Genes in Chemogenomics Tissues where Essential in the Avana Dataset (DepMap 20Q1)
Compound Hit
| Screen | Score |
|---|---|
| Brefeldin A 0.02μM R00 exp8 | -1.86 |
| DABN 20μM R00 exp17 | -1.81 |
| Nifuroxazide 5μM R03 exp102 | 1.74 |
| Chloramphenicol 2μM R00 exp12 | 1.87 |
| Caffeine 2600μM R08 exp463 | 1.9 |
| Ibrutinib 1μM R07 exp372 | 1.91 |
Most Correlated Genes in Chemogenomics
| Gene | Correlation |
|---|---|
| HGC6.3 | 0.647 |
| RAD51 | 0.525 |
| C2orf27B | 0.52 |
| CDC45 | 0.511 |
| TFIP11 | 0.509 |
| C1QTNF9B | 0.506 |
| ORC6 | 0.504 |
| SNRPA1 | 0.498 |
| TBC1D3H | 0.498 |
| XYLT2 | 0.495 |
| DTL | 0.495 |
| SLC4A1 | 0.491 |
| CCNA2 | 0.49 |
| TBC1D3G | 0.489 |
| PSMA6 | 0.489 |
| KCTD17 | 0.488 |
| TCEB3C | 0.487 |
| CACTIN | 0.483 |
| PSMC2 | 0.483 |
| RPS19BP1 | 0.482 |
| TCEB3CL2 | 0.48 |
| PSMB4 | 0.479 |
| UTP3 | 0.479 |
| SUPT5H | 0.477 |
| DDTL | 0.475 |
| PLA2G4F | 0.475 |
| MT1E | 0.473 |
| RPL35 | 0.472 |
| NUPL1 | 0.471 |
| RRN3 | 0.471 |
| RPS5 | 0.47 |
| COPG1 | 0.468 |
| CCDC64B | 0.465 |
| TBC1D3F | 0.464 |
| TICRR | 0.464 |
| DOCK6 | 0.461 |
| RRP7A | 0.458 |
| NFATC4 | 0.458 |
| TCEB3CL | 0.458 |
| UPF1 | 0.457 |
| ATP6V1C1 | 0.456 |
| POLR2L | 0.455 |
| GOLGA6L3 | 0.455 |
| COL2A1 | 0.454 |
| TBC1D3C | 0.453 |
| ANKLE1 | 0.453 |
| IK | 0.453 |
| CEBPZ | 0.452 |
| AHCTF1 | 0.451 |
| PWP2 | 0.451 |
| ZNF830 | 0.451 |
| CBWD3 | 0.449 |
| GAR1 | 0.448 |
| LOC643669 | 0.448 |
| NIPBL | 0.447 |
| NSF | 0.444 |
| CBWD5 | 0.444 |
| TP53TG3 | 0.443 |
| TP53TG3B | 0.443 |
| TP53TG3C | 0.443 |
| CDC73 | 0.442 |
| FAM160A1 | 0.442 |
| PSMB3 | 0.441 |
| CHD4 | 0.441 |
| VASN | 0.441 |
| POLE | 0.44 |
| SEC13 | 0.439 |
| POLR2J3 | 0.439 |
| TSPY8 | 0.438 |
| NUP160 | 0.438 |
| MYO1H | 0.438 |
| ANKLE2 | 0.435 |
| ZNF574 | 0.435 |
| TBC1D3E | 0.435 |
| TBC1D3I | 0.435 |
| TBC1D3K | 0.434 |
| ATXN1 | 0.434 |
| TBC1D3L | 0.434 |
| DIDO1 | 0.434 |
| ORC1 | 0.433 |
| TBC1D3 | 0.433 |
| SMG7 | 0.432 |
| C14orf93 | 0.432 |
| PSMC5 | 0.431 |
| COPE | 0.431 |
| ZNF655 | 0.431 |
| NPIPB5 | 0.43 |
| PSMC1 | 0.43 |
| CBWD6 | 0.429 |
| LRR1 | 0.429 |
| UBAP1 | 0.429 |
| RPS9 | 0.429 |
| NARFL | 0.429 |
| WDR87 | 0.429 |
| RPS12 | 0.429 |
| CHMP2A | 0.428 |
| PSMB2 | 0.428 |
| CDC6 | 0.427 |
| DDX56 | 0.427 |
| INTS5 | 0.426 |
| SSH2 | 0.426 |
| RPS2 | 0.426 |
| SAP30BP | 0.424 |
| ZFAND5 | 0.424 |
| RPSA | 0.423 |
| OSBP | 0.423 |
| PSMD3 | 0.423 |
| ISCU | 0.423 |
| GOLGA8O | 0.422 |
| INTS6 | 0.422 |
| PDE4DIP | 0.421 |
| HIST2H2BF | 0.421 |
| STIL | 0.418 |
| TUBA8 | 0.418 |
| POLA2 | 0.417 |
| COPB1 | 0.415 |
| RPS28 | 0.415 |
| AAMP | 0.415 |
| CHAF1A | 0.414 |
| TWISTNB | 0.413 |
| EXOSC5 | 0.413 |
| VPS54 | 0.412 |
| CCDC116 | 0.412 |
| RRP15 | 0.411 |
| GOLGA6A | 0.411 |
| GOLGA6L4 | 0.411 |
| RPS3A | 0.41 |
| PSMD14 | 0.41 |
| OGFR | 0.41 |
| ARCN1 | 0.409 |
| PSMD11 | 0.408 |
| POLA1 | 0.408 |
| HIST1H2BE | 0.408 |
| RPL9 | 0.407 |
| CTAGE4 | 0.407 |
| AKIRIN2 | 0.405 |
| NOL7 | 0.405 |
| CLN6 | 0.404 |
| BRD2 | 0.404 |
| KIF3C | 0.404 |
| DDX47 | 0.403 |
| PSMA7 | 0.403 |
| TIMELESS | 0.402 |
| COPA | 0.402 |
| SYT9 | 0.402 |
| RPS21 | 0.401 |
| CKAP5 | 0.401 |
| C2orf27A | 0.4 |
| SNX15 | 0.4 |
| AQR | 0.4 |
| RPLP1 | 0.4 |
| PSMD7 | 0.4 |
| HIVEP3 | 0.4 |
| PAN3 | 0.4 |
Tissues where Essential in the Avana Dataset (DepMap 20Q1)
Global Fraction of Cell Lines Where Essential: 0/739
| Tissue | Fraction Of Cell Lines Where Essential |
|---|---|
| 1290807.0 | 0/1 |
| 909776.0 | 0/1 |
| bile duct | 0/28 |
| blood | 0/28 |
| bone | 0/26 |
| breast | 0/33 |
| central nervous system | 0/56 |
| cervix | 0/4 |
| colorectal | 0/17 |
| esophagus | 0/13 |
| fibroblast | 0/1 |
| gastric | 0/16 |
| kidney | 0/21 |
| liver | 0/20 |
| lung | 0/75 |
| lymphocyte | 0/16 |
| ovary | 0/26 |
| pancreas | 0/24 |
| peripheral nervous system | 0/16 |
| plasma cell | 0/15 |
| prostate | 0/1 |
| skin | 0/24 |
| soft tissue | 0/9 |
| thyroid | 0/2 |
| upper aerodigestive | 0/22 |
| urinary tract | 0/29 |
| uterus | 0/5 |
Essentiality in NALM6
- Essentiality Rank: 1893
- Expression level (log2 read counts): 4.81
Expression Distribution
ACSF2 Expression in NALM6 Cells: 4.81